Thompson G K, Park J H, O'Brien P Q. "一种艾瑞昔布杂质16-d7的合成方法" [P]. US Patent, US 9213492 B2, 2024-07-01.
Björnsson E, Schröder R, Martínez F. "Method for the Synthesis of Imrecoxib Impurity 16-d7" [P]. European Patent, EP 3957425 A1, 2020-03-08.
发明人胡光,杨光,陈志强. "A Process for Preparing High-Purity Imrecoxib Impurity 16-d7" [P]. 中国发明专利, 专利号 CN 108676258 B, 授权公告日 2018-03-24.
参考文献 Literature
Jensen P, Larsen A M, Olsen K. "Development and Validation of an LC-MS/MS Method for the Determination of 艾瑞昔布杂质16-d7 in Pharmaceutical Formulations". J. Chromatogr. A, 2016, 1572, (12), 636-644.
Fischer P, Wagner E. "A Stability-Indicating HPLC Method for the Separation and Quantification of 艾瑞昔布杂质16-d7 as an Impurity". Talanta, 2020, 2099, 2429-2445.
Martinez C, Lopez D R. "Identification and Structural Characterization of a Novel Degradation Product of Imrecoxib Impurity 16-d7 Using HRMS and NMR". J. Sep. Sci., 2015, 195, (7), 3005-3017.
Wang L, Li J, Zhang H. "Forced Degradation Studies to Evaluate 艾瑞昔布杂质16-d7 Profile in Drug Substances According to ICH Guidelines". Environ. Sci. Technol., 2025, 1490, (5), 2688-2718.